Kidney Disease - Pipeline Review, H1 2014 Released On 24th February 2015
Summary ‘Kidney Disease - Pipeline Review, H1 2014’, provides an overview of the Kidney Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Kidney Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Disease and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Browse complete Report on: http://www.jsbmarketresearch.com/healthcare-medical/r-kidney-disease-pipelinereview-h1-2014-160397
Scope The report provides a snapshot of the global therapeutic landscape of Kidney Disease The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Kidney Disease and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Kidney Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Kidney Disease pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Kidney Disease Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Kidney Disease pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Table of Contents 1 Introduction REPORT COVERAGE Kidney Disease Overview JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Therapeutics Development Pipeline Products for Kidney Disease – Overview Pipeline Products for Kidney Disease – Comparative Analysis Kidney Disease – Therapeutics under Development by Companies Kidney Disease – Therapeutics under Investigation by Universities/Institutes Kidney Disease – Pipeline Products Glance Late Stage Products Clinical Stage Products Early Stage Products Kidney Disease – Products under Development by Companies Kidney Disease – Products under Investigation by Universities/Institutes Kidney Disease – Companies Involved in Therapeutics Development F. Hoffmann-La Roche Ltd. Sanofi Nektar Therapeutics Chugai Pharmaceutical Co., Ltd. LEO Pharma A/S Teva Pharmaceutical Industries Limited Zydus Cadila Healthcare Limited Gentium S.p.A. JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Celldex Therapeutics, Inc. Osteologix Holdings Plc. Ahn-Gook Pharmaceutical Co., Ltd. DiaMedica Inc. Upsher-Smith Laboratories, Inc. TetraLogic Pharmaceuticals ChemoCentryx, Inc. Anexon, Inc. Otsuka Holdings Co., Ltd. BIOPROJET SCR Advicenne Pharma ZS Pharma, Inc. G1 Therapeutics, Inc. AbbVie Inc. Kidney Disease – Therapeutics Assessment Assessment by Monotherapy Products Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Drug Profiles ADV-7809 - Drug Profile Product Description Mechanism of Action R&D Progress benazepril hydrochloride - Drug Profile Product Description Mechanism of Action R&D Progress ADV-7103 - Drug Profile Product Description Mechanism of Action R&D Progress tolvaptan - Drug Profile Product Description Mechanism of Action R&D Progress methylprednisolone - Drug Profile Product Description Mechanism of Action JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress ZS-9 - Drug Profile Product Description Mechanism of Action R&D Progress AGNPN-803 - Drug Profile Product Description Mechanism of Action R&D Progress hydrocodone bitartrate ER - Drug Profile Product Description Mechanism of Action R&D Progress LEO-27847 - Drug Profile Product Description Mechanism of Action R&D Progress DM-199 - Drug Profile Product Description Mechanism of Action JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress tiprolisant - Drug Profile Product Description Mechanism of Action R&D Progress ABT-614 - Drug Profile Product Description Mechanism of Action R&D Progress ANX-042 - Drug Profile Product Description Mechanism of Action R&D Progress CCX-872 - Drug Profile Product Description Mechanism of Action R&D Progress RG-7641 - Drug Profile Product Description Mechanism of Action JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress CDX-1189 - Drug Profile Product Description Mechanism of Action R&D Progress CU-NP - Drug Profile Product Description Mechanism of Action R&D Progress Necrostatin Program - Drug Profile Product Description Mechanism of Action R&D Progress Oligotide - Drug Profile Product Description Mechanism of Action R&D Progress NKTR-228 - Drug Profile Product Description Mechanism of Action JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress CCR2 Antagonist - Drug Profile Product Description Mechanism of Action R&D Progress CH-5451098 - Drug Profile Product Description Mechanism of Action R&D Progress SkQR-1 - Drug Profile Product Description Mechanism of Action R&D Progress TNT-009 - Drug Profile Product Description Mechanism of Action R&D Progress SLR-080811 Derivative - Drug Profile Product Description Mechanism of Action JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress AVE-0991 - Drug Profile Product Description Mechanism of Action R&D Progress NBS-101 - Drug Profile Product Description Mechanism of Action R&D Progress Prod-1 - Drug Profile Product Description Mechanism of Action R&D Progress messenger RNA Therapeutics Program - Drug Profile Product Description Mechanism of Action R&D Progress AHRO-200 - Drug Profile Product Description Mechanism of Action JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress CDK-4/6 Inhibitors As Renal Protectants - Drug Profile Product Description Mechanism of Action R&D Progress A77-Based Monobody - Drug Profile Product Description Mechanism of Action R&D Progress Kidney Disease – Recent Pipeline Updates Kidney Disease – Dormant Projects Kidney Disease – Product Development Milestones Featured News & Press Releases Nov 07, 2013: La Jolla Pharmaceutical Company Presents Data at the Annual American Society of Nephrology Conference May 02, 2013: Arena Pharma Withdraws European Marketing Authorization Application For Belviq Mar 28, 2013: Cytori Therapeutics Receives US Patent Covering Method Of Treating Renal Diseases Using Adipose-derived Regenerative Cells Jan 08, 2013: Medicure Announces Filing Of sNDA For Aggrastat Label Change Nov 06, 2012: Lexicon Pharma Presents Phase IIb Results Of LX4211 At American Heart Association Annual Conference JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Oct 17, 2012: Raptor Pharma Announces Presentation Of Procysbi Extension Study Data At American Society Of Nephrology Annual Meeting Aug 03, 2012: New Published Data Demonstrate Endocytes Targeted Small Molecule Drug Conjugate Approach Shows Promising Results In Polycystic Kidney Disease Model Mar 05, 2012: Medistem To Begin Clinical Trials Using ERC Stem Cells For Renal, Lung And Peripheral Artery Disease May 11, 2011: Rockwell Medical Receives US Patent For SFP Packaging And Method Of Use Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer List Of Tables Number of Products under Development for Kidney Disease, H1 2014 Number of Products under Development for Kidney Disease – Comparative Analysis, H1 2014 Number of Products under Development by Companies, H1 2014 Number of Products under Development by Companies, H1 2014 (Contd..1) Number of Products under Investigation by Universities/Institutes, H1 2014 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Comparative Analysis by Late Stage Development, H1 2014 Comparative Analysis by Clinical Stage Development, H1 2014 Comparative Analysis by Early Stage Development, H1 2014 Products under Development by Companies, H1 2014 Products under Investigation by Universities/Institutes, H1 2014 Kidney Disease – Pipeline by F. Hoffmann-La Roche Ltd., H1 2014 Kidney Disease – Pipeline by Sanofi, H1 2014 Kidney Disease – Pipeline by Nektar Therapeutics, H1 2014 Kidney Disease – Pipeline by Chugai Pharmaceutical Co., Ltd., H1 2014 Kidney Disease – Pipeline by LEO Pharma A/S, H1 2014 Kidney Disease – Pipeline by Teva Pharmaceutical Industries Limited, H1 2014 Kidney Disease – Pipeline by Zydus Cadila Healthcare Limited, H1 2014 Kidney Disease – Pipeline by Gentium S.p.A., H1 2014 Kidney Disease – Pipeline by Celldex Therapeutics, Inc., H1 2014 Kidney Disease – Pipeline by Osteologix Holdings Plc., H1 2014 Kidney Disease – Pipeline by Ahn-Gook Pharmaceutical Co., Ltd., H1 2014 Kidney Disease – Pipeline by DiaMedica Inc., H1 2014 Kidney Disease – Pipeline by Upsher-Smith Laboratories, Inc., H1 2014 Kidney Disease – Pipeline by TetraLogic Pharmaceuticals, H1 2014 Kidney Disease – Pipeline by ChemoCentryx, Inc., H1 2014 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Kidney Disease – Pipeline by Anexon, Inc., H1 2014 Kidney Disease – Pipeline by Otsuka Holdings Co., Ltd., H1 2014 Kidney Disease – Pipeline by BIOPROJET SCR, H1 2014 Kidney Disease – Pipeline by Advicenne Pharma, H1 2014 Kidney Disease – Pipeline by ZS Pharma, Inc., H1 2014 Kidney Disease – Pipeline by G1 Therapeutics, Inc., H1 2014 Kidney Disease – Pipeline by AbbVie Inc., H1 2014 Assessment by Monotherapy Products, H1 2014 Number of Products by Stage and Target, H1 2014 Number of Products by Stage and Mechanism of Action, H1 2014 Number of Products by Stage and Route of Administration, H1 2014 Number of Products by Stage and Molecule Type, H1 2014 Kidney Disease Therapeutics – Recent Pipeline Updates, H1 2014 Kidney Disease – Dormant Projects, H1 2014 List Of Figures Number of Products under Development for Kidney Disease, H1 2014 Number of Products under Development for Kidney Disease – Comparative Analysis, H1 2014 Number of Products under Development by Companies, H1 2014 Number of Products under Investigation by Universities/Institutes, H1 2014 Comparative Analysis by Late Stage Development, H1 2014 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Comparative Analysis by Clinical Stage Development, H1 2014 Comparative Analysis by Early Stage Products, H1 2014 Assessment by Monotherapy Products, H1 2014 Number of Products by Top 10 Target, H1 2014 Number of Products by Stage and Top 10 Target, H1 2014 Number of Products by Top 10 Mechanism of Action, H1 2014 Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 Number of Products by Top 10 Route of Administration, H1 2014 Number of Products by Stage and Top 10 Route of Administration, H1 2014 Number of Products by Top 10 Molecule Type, H1 2014 Number of Products by Stage and Top 10 Molecule Type, H1 2014 54
Special Discount On Global Markets Direct Market Research Reports at JSB (Discount Valid till 28th February, 2015) Buy 2 Reports – 10% discount Buy 3 to 5 Reports – 15% Discount Buy 5 to 10 Reports – 20% Discount Buy 10+ Reports – 25% Discount Click here an available Discount Offer On Global Markets Direct Market Research Reports: http://www.jsbmarketresearch.com/discount.php For more inquiries, contact at +91 - 998 729 5242/contact@jsbmarketresearch.com
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Product Price : License Type
Price
$ 2000
Site Licence
$ 4000
Enterprise Wide Licence
$ 6000
Related reports: European Non-Invasive & Minimally Invasive Cardiac Output Monitoring Devices Market Europe Laboratory Information System Market Global Top 10 Medical Devices Companies: Company Guide Cystic Fibrosis Market in Europe 2015-2019 Global Cell Culture Protein Surface Coating Market 2015-2019 Global Infertility Market 2015-2019 Global Patient Temperature Management Market 2015-2019 Global Preventable Vaccines Market 2015-2019 Global Transplantation Market 2015-2019 Global Ultrasound Equipment Market 2015-2019 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stopshop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on “Kidney Disease - Pipeline Review, H1 2014� http://www.jsbmarketresearch.com/healthcare-medical/r-kidney-disease-pipeline-review-h12014-160397
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/